DXP reductoisomerase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
DXR <scene name='70/708083/Cv/8'>active site</scene> contains Mn<sup>+2</sup> cation and the product analog fosmidomycin. <scene name='70/708083/Cv/9'>Click here to see NADPH binding site</scene> (water molecules shown as red spheres).<ref>PMID:23819803</ref>
DXR <scene name='70/708083/Cv/8'>active site</scene> contains Mn<sup>+2</sup> cation and the product analog fosmidomycin. <scene name='70/708083/Cv/9'>Click here to see NADPH binding site</scene> (water molecules shown as red spheres).<ref>PMID:23819803</ref>
 +
 +
== 3D Structures of DXP reductoisomerase==
 +
 +
[[DXP reductoisomerase 3D Structures]]
</StructureSection>
</StructureSection>

Revision as of 11:12, 7 February 2023

DXP reductoisomerase complex with NADPH, Mn+2 ion (green) and anti-malaria drug fosmidomycin (PDB code 3zhy)

Drag the structure with the mouse to rotate

3D Structures of DXP reductoisomerase

Updated on 07-February-2023

References

  1. Takahashi S, Kuzuyama T, Watanabe H, Seto H. A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9879-84. PMID:9707569
  2. Jansson AM, Wieckowska A, Bjorkelid C, Yahiaoui S, Sooriyaarachchi S, Lindh M, Bergfors T, Dharavath S, Desroses M, Suresh S, Andaloussi M, Nikhil R, Sreevalli S, Srinivasa BR, Larhed M, Jones TA, Karlen A, Mowbray SL. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues. J Med Chem. 2013 Aug 8;56(15):6190-9. doi: 10.1021/jm4006498. Epub 2013 Jul 17. PMID:23819803 doi:http://dx.doi.org/10.1021/jm4006498

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools